Maria L. Bageta
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Factors Impacting Laxative Use in Children and Adolescents With Epidermolysis Bullosa: Single Centre Retrospective Study.
Journal: Journal of paediatrics and child health
Published: May 26, 2026
O05 Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition.
O05 Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition.
Journal: The British journal of dermatology
Published: December 18, 2025
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.
Journal: The British journal of dermatology
Published: December 18, 2025
Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa patients with nonsense COL7A1 mutations.
Journal: Clinical and experimental dermatology
Published: November 26, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial.
Journal: Orphanet journal of rare diseases
Published: October 23, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.
Journal: BMJ open
Published: May 21, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase.
Journal: EClinicalMedicine
Published: March 11, 2025
Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline.
Journal: The British journal of dermatology
Published: January 03, 2025
Early use of nasogastric tubes may lead to serious oesophageal complications in patients with severe epidermolysis bullosa.
Journal: Clinical and experimental dermatology
Published: February 25, 2024
Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 21, 2023
Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa-A series of six pediatric patients.
Journal: Pediatric dermatology
Published: January 24, 2023
The impact of using a multistrain probiotic supplement on gastrointestinal function in children and adolescents with severe recessive dystrophic epidermolysis bullosa.
Journal: Clinical and experimental dermatology
Published: November 09, 2022
Last Updated: 09/26/2026